Challenges in Veterinary Vaccine Development and Immunization

Overview

Journal Methods Mol Biol

Specialty Molecular Biology

Date 2016 Apr 15

PMID 27076287

Citations 12

Authors

Mark A Chambers

Simon P Graham

Roberto M La Ragione

Affiliations

Soon will be listed here.

Abstract

In approaching the development of a veterinary vaccine, researchers must choose from a bewildering array of options that can be combined to enhance benefit. The choice and combination of options is not just driven by efficacy, but also consideration of the cost, practicality, and challenges faced in licensing the product. In this review we set out the different choices faced by veterinary vaccine developers, highlight some issues, and propose some pressing needs to be addressed.

Citing Articles

Current Challenges of Vaccination in Fish Health Management.

Kumar A, Middha S, Menon S, Paital B, Gokarn S, Nelli M Animals (Basel). 2024; 14(18).

PMID: 39335281 PMC: 11429256. DOI: 10.3390/ani14182692.

Evaluation of livestock farmers' knowledge, attitudes and practices regarding the use of veterinary vaccines in Southwest Ethiopia.

Robi D, Bogale A, Temteme S, Aleme M, Urge B Vet Med Sci. 2023; 9(6):2871-2884.

PMID: 37788141 PMC: 10650347. DOI: 10.1002/vms3.1290.

Bovine tuberculosis in India: The need for One Health approach and the way forward.

Ramanujam H, Palaniyandi K One Health. 2023; 16:100495.

PMID: 36817978 PMC: 9932178. DOI: 10.1016/j.onehlt.2023.100495.

Update on the Inactivation Procedures for the Vaccine Development Prospects of a New Highly Virulent RGNNV Isolate.

Falco A, Bello-Perez M, Diaz-Puertas R, Mold M, Adamek M Vaccines (Basel). 2021; 9(12).

PMID: 34960187 PMC: 8705346. DOI: 10.3390/vaccines9121441.

Advances in Development and Application of Influenza Vaccines.

Chen J, Wang J, Zhang J, Ly H Front Immunol. 2021; 12:711997.

PMID: 34326849 PMC: 8313855. DOI: 10.3389/fimmu.2021.711997.

References

Cao J, Wang X, Du Y, Li Y, Wang X, Jiang P . CD40 ligand expressed in adenovirus can improve the immunogenicity of the GP3 and GP5 of porcine reproductive and respiratory syndrome virus in swine. Vaccine. 2010; 28(47):7514-22. DOI: 10.1016/j.vaccine.2010.09.002. View

Thomas C, Young N, Heaney J, Collins M, Brownlie J . Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus. Vaccine. 2009; 27(17):2387-93. DOI: 10.1016/j.vaccine.2009.02.010. View

van Oirschot J, Bruschke C, van Rijn P . Vaccination of cattle against bovine viral diarrhoea. Vet Microbiol. 1999; 64(2-3):169-83. DOI: 10.1016/s0378-1135(98)00268-5. View

Lunn D, Townsend H . Equine vaccination. Vet Clin North Am Equine Pract. 2000; 16(1):199-226, viii. DOI: 10.1016/s0749-0739(17)30127-x. View

Osorio F, Galeota J, Nelson E, Brodersen B, Doster A, Wills R . Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity. Virology. 2002; 302(1):9-20. DOI: 10.1006/viro.2002.1612. View

Coppo M, Noormohammadi A, Browning G, Devlin J . Challenges and recent advancements in infectious laryngotracheitis virus vaccines. Avian Pathol. 2013; 42(3):195-205. DOI: 10.1080/03079457.2013.800634. View

Van Immerseel F, Methner U, Rychlik I, Nagy B, Velge P, Martin G . Vaccination and early protection against non-host-specific Salmonella serotypes in poultry: exploitation of innate immunity and microbial activity. Epidemiol Infect. 2005; 133(6):959-78. PMC: 2870330. DOI: 10.1017/S0950268805004711. View

Roeder P, Mariner J, Kock R . Rinderpest: the veterinary perspective on eradication. Philos Trans R Soc Lond B Biol Sci. 2013; 368(1623):20120139. PMC: 3720037. DOI: 10.1098/rstb.2012.0139. View

Harpin S, Hurley D, Mbikay M, Talbot B, ElAzhary Y . Vaccination of cattle with a DNA plasmid encoding the bovine viral diarrhoea virus major glycoprotein E2. J Gen Virol. 1999; 80 ( Pt 12):3137-3144. DOI: 10.1099/0022-1317-80-12-3137. View

10.

Wilson-Welder J, Torres M, Kipper M, Mallapragada S, Wannemuehler M, Narasimhan B . Vaccine adjuvants: current challenges and future approaches. J Pharm Sci. 2008; 98(4):1278-316. PMC: 8092333. DOI: 10.1002/jps.21523. View

11.

Zinsstag J, Schelling E, Wyss K, Mahamat M . Potential of cooperation between human and animal health to strengthen health systems. Lancet. 2005; 366(9503):2142-5. DOI: 10.1016/S0140-6736(05)67731-8. View

12.

Shi M, Lam T, Hon C, Hui R, Faaberg K, Wennblom T . Molecular epidemiology of PRRSV: a phylogenetic perspective. Virus Res. 2010; 154(1-2):7-17. DOI: 10.1016/j.virusres.2010.08.014. View

13.

Roques E, Girard A, St-Louis M, Massie B, Gagnon C, Lessard M . Immunogenic and protective properties of GP5 and M structural proteins of porcine reproductive and respiratory syndrome virus expressed from replicating but nondisseminating adenovectors. Vet Res. 2013; 44:17. PMC: 3608016. DOI: 10.1186/1297-9716-44-17. View

14.

Clifton-Hadley F, Breslin M, Venables L, Sprigings K, Cooles S, Houghton S . A laboratory study of an inactivated bivalent iron restricted Salmonella enterica serovars Enteritidis and Typhimurium dual vaccine against Typhimurium challenge in chickens. Vet Microbiol. 2002; 89(2-3):167-79. DOI: 10.1016/s0378-1135(02)00169-4. View

15.

Arnold M, Gosling R, La Ragione R, Davies R, Martelli F . Estimation of the impact of vaccination on faecal shedding and organ and egg contamination for Salmonella Enteritidis, Salmonella Typhiumurium and monophasic Salmonella Typhimurium. Avian Pathol. 2014; 43(2):155-63. DOI: 10.1080/03079457.2014.896990. View

16.

van den Berg T, Lambrecht B, Marche S, Steensels M, Van Borm S, Bublot M . Influenza vaccines and vaccination strategies in birds. Comp Immunol Microbiol Infect Dis. 2007; 31(2-3):121-65. DOI: 10.1016/j.cimid.2007.07.004. View

17.

Fray M, Paton D, Alenius S . The effects of bovine viral diarrhoea virus on cattle reproduction in relation to disease control. Anim Reprod Sci. 2000; 60-61:615-27. DOI: 10.1016/s0378-4320(00)00082-8. View

18.

Vanhee M, Costers S, Van Breedam W, Geldhof M, Van Doorsselaere J, Nauwynck H . A variable region in GP4 of European-type porcine reproductive and respiratory syndrome virus induces neutralizing antibodies against homologous but not heterologous virus strains. Viral Immunol. 2010; 23(4):403-13. PMC: 2928701. DOI: 10.1089/vim.2010.0025. View

19.

Samsom J, De Bruin T, Voermans J, Meulenberg J, Pol J, Bianchi A . Changes of leukocyte phenotype and function in the broncho-alveolar lavage fluid of pigs infected with porcine reproductive and respiratory syndrome virus: a role for CD8(+) cells. J Gen Virol. 2000; 81(Pt 2):497-505. DOI: 10.1099/0022-1317-81-2-497. View

20.

Loemba H, Mounir S, Mardassi H, Archambault D, Dea S . Kinetics of humoral immune response to the major structural proteins of the porcine reproductive and respiratory syndrome virus. Arch Virol. 1996; 141(3-4):751-61. PMC: 7086943. DOI: 10.1007/BF01718333. View